wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42927772-CC131006-2916-4A7A-95AF-AC019D8F8E3C
Q42927772-CC131006-2916-4A7A-95AF-AC019D8F8E3C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42927772-CC131006-2916-4A7A-95AF-AC019D8F8E3C
Phase III trials with docetaxel-based combinations for metastatic castration-resistant prostate cancer: time to learn from past experiences.
P2860
Q42927772-CC131006-2916-4A7A-95AF-AC019D8F8E3C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42927772-CC131006-2916-4A7A-95AF-AC019D8F8E3C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
064be3bd66fb84e162be5b570f2f0d681c579feb
P2860
Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: a double-